BioCentury
ARTICLE | Company News

Roche reorganizing diagnostics business

April 24, 2013 1:05 AM UTC

Roche (SIX:ROG; OTCQX:RHHBY) said it will dissolve its Roche Applied Science business and integrate the unit's product portfolio into its other diagnostics business areas by year end. The PCR technology and nucleic acid product lines of Applied Science will become part of Roche Molecular Diagnostics, while Applied Science's portfolio of platforms and reagents will be moved to Roche Professional Diagnostics. Roche said the changes will result in a headcount reduction of about 170. ...